News

Cingulate's Upcoming Participation in Benzinga Event

Cingulate's Upcoming Participation in Benzinga Event

Cingulate Inc. to Participate in Benzinga All Access Event

Cingulate Inc. (NASDAQ: CING), a leading biopharmaceutical company, is gearing up to take part in the Benzinga All Access event on August 28, 2024. The event will feature a presentation by Cingulate's Chairman and CEO, Shane J. Schaffer, PharmD, who will provide an in-depth overview of the company starting at 10:30 a.m. CST.

Key Topics of Discussion

During his presentation, Dr. Schaffer will discuss Cingulate's recent progress, particularly emphasizing the newly awarded European patent. He plans to examine the current state of the Attention Deficit Hyperactivity Disorder (ADHD) market and how Cingulate's innovative Precision Timed Release™ (PTR™) technology could potentially be applied to various therapeutic areas.

Advancements in Drug Delivery

Cingulate is harnessing its cutting-edge PTR technology to develop and improve a range of next-generation pharmaceuticals. The company's commitment to enhancing patient experiences with treatment regimens reflects their dedication to addressing prevalent medical issues. The products created under Cingulate's direction aim to decrease dosing frequency and optimize therapeutic results, especially for those diagnosed with ADHD.

Progress in ADHD Treatment

The demand for effective treatments for ADHD is highlighted by the condition's widespread impact on daily life. Research conducted by Cingulate suggests that their targeted approach using the PTR platform can provide a vital solution by administering medication in a more controlled way. This could lead to better adherence among patients, ultimately enhancing the overall effectiveness of treatment.

Future Goals for Cingulate

As Cingulate Inc. continues its path of innovation, the company plans to explore and assess additional therapeutic areas where the PTR technology might be advantageous. This investigation will not only focus on ADHD but may also extend to anxiety disorders and other conditions that require careful management.

Company Overview

Cingulate Inc. is strategically positioned at the forefront of biopharmaceutical innovations, utilizing its advanced technology. With its headquarters located in a dynamic commercial center, the company is well-equipped to forge strong partnerships and collaborations within the healthcare industry. Cingulate's growth trajectory highlights the essential role that innovative drug delivery solutions play in the market.

Contact Information

For more information, the Investor Relations team at Cingulate is available to provide detailed insights. Interested individuals can reach out to:

Thomas Dalton
Head of Investor & Public Relations, Cingulate
Email: TDalton@cingulate.com
Phone: 913-942-2301

Matt Kreps
Darrow Associates
Email: mkreps@darrowir.com
Phone: 214-597-8200

Frequently Asked Questions

What is the Benzinga All Access event?

The Benzinga All Access event serves as a platform for companies to share updates and insights with investors and the public, showcasing their latest developments and strategies.

Who will represent Cingulate at the event?

Shane J. Schaffer, PharmD, the Chairman and CEO of Cingulate, will be the company's representative during the event.

What is Cingulate's PTR technology?

Cingulate's Precision Timed Release™ (PTR™) technology is a proprietary drug delivery system designed to enhance the dosing regimen of pharmaceuticals, particularly for conditions like ADHD.

What conditions is Cingulate focusing on with its products?

Cingulate primarily targets Attention Deficit Hyperactivity Disorder (ADHD) and is also exploring additional therapeutic areas, including anxiety disorders.

How can investors obtain more information about Cingulate?

Investors can contact Cingulate's Investor Relations team via email or phone for further details regarding the company's operations and stock performance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 249

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 150

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 114

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 9

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 244

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 168

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 74

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 159

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 74

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 222

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading

Top 5 Most Recently Viewed Articles

CrossCountry Mortgage Expands Asset Management with Growth

Updated Category News Views 348

Expansion of CrossCountry Capital CrossCountry Capital, part of CrossCountry Mortgage, is making headlines with its impressive growth. Recently, they announced that they have received over $1 billion in equity capital commitments, paving the way for more than $20 billion in new loan investments. This development reflects the rapid evolution of their asset management...

Continue Reading
PBIRx Strengthens Leadership to Elevate Client Services

Updated Category News Views 65

PBIRx, Inc. made waves in the pharmacy benefit consulting world back in 2024 by promoting Stacy Mathews to Director of Account Management. You know what that means? Major shifts on the horizon for this player trying to navigate an ever-changing healthcare landscape. Stacy Mathews: The New Force Behind PBIRx Stacy’s rise within PBIRx wasn’t just a lucky break; she came...

Continue Reading
NatGold Digital Crosses Into European Crypto Territory

Updated Category News Views 93

Amidst the ever-turning gears of digital finance, NatGold Digital has staked its claim, looking to make waves across the Atlantic. As per the word from Miami, they're bringing their fancy digital mining show to the biggest digital asset parade grounds: Europe. It's not just a dip of the toe, either—they're gunning for the whole European Economic Area. A bit ambitious,...

Continue Reading
Cotti's Journey to 10,000 Stores: Challenges and Strategies Ahead

Updated Category News Views 581

Cotti's Journey to Milestone Achievement Cotti Coffee has recently celebrated a remarkable achievement, reaching the milestone of 10,000 stores in a span of just two years. This expansion has been fueled by a fierce price war against its rival, Luckin Coffee. While this rapid growth is impressive, questions arise regarding the sustainability of Cotti's low-price strategy...

Continue Reading
CIRO Schedules Hearing for Allegations Against Abid Hossain

Updated Category News Views 145

Overview of the Disciplinary Hearing A hearing has been set before a panel of the Canadian Investment Regulatory Organization (CIRO) regarding allegations against Abid Hossain. This case arises under the Mutual Fund Dealer Rules, highlighting the importance of integrity in financial services. Public Access to the Hearing The upcoming disciplinary hearing will be open to...

Continue Reading